請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48347
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳秀熙 | |
dc.contributor.author | Bih-Tsuen Hsu | en |
dc.contributor.author | 徐碧村 | zh_TW |
dc.date.accessioned | 2021-06-15T06:53:24Z | - |
dc.date.available | 2011-03-03 | |
dc.date.copyright | 2011-03-03 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-02-12 | |
dc.identifier.citation | Abdul Hamid Zaygar,et al.(2008) Prevalence of diabetes mellitus and other abnormalities of glucose tolerance in young adults aged 20-40 years in North India(Kashmir Valley).Diabetes Research and Clinical Practice.82,276-281.
Aekplakorn W, Bunnag P,Woodward M,et al.(2006) A risk score for predicting incident diabetes in the Thai population.Diabetes Care.29(8):1872-1877. Ali O,Tan TT,Sakinah O,Khald BA, Wu LL,Ng ML.(1993) Prevalence of NIDDM and impaired glucose tolerance in Aborigines and Malays in Malaysia and their relationship to sociodemographic, health, and nutritional factors, Diabetes Care.16,68-75. Allison PD. (2001)Missing Data Thousand Oaks, CA: Sage Publications. American Diabetes Association.(2004)Diagnosis and Classification of Diabetes Mellitus. Diabetes Care.27, (Suppl 1)S5-S10. American Diabetes Association:Clinical Practice Recommendations.(2003) Implications of the Diabetes Control and Complications Trial. Diabetes Care; (Suppl 1) S25-S27. American Diabetes Association.(2010)Diagnosis and classification of diabetes mellitus. Diabetes Care.33 Suppl 1:S62-9. Babu A,Fogelfeld L.(2006)Metabolic syndrome and prediabetes. Dis Mon 52,55-144. Balkau B,Deanfield JE,Despres JP.et al.(2007)International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation.116(17):1942-1951. Barzilay JI,Spiekerman CF,Wahl PW,Kuller LH,Cushman M,Furberg CD,et al. (1999)Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria,Lancet 354,622-625. Beizer RA.(1990)Prevalence of abnormal glucose tolerance in six Solomon Islands populations,Am.J.Phys.Anthropol.81,471-482. Buchanan TA,Xiang AH,Peters RK,et al.(2002)Preservation of pancreatic s-Cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 51,2796-2803. Chang CJ,Lu FH,et al.(2000)Epidemiologic study of type 2 diabetes in Taiwan. Diabetes Research and Clinical Practice 50 Suppl.2,S49-S59. Chang YC,Chang TJ,Jiang YD,et al.(2007)Association study of the genetic polymorphisms of the transcription factor 7-like 2 (TCF7L2) gene and type 2 diabetes in the Chinese population.Diabetes.56(10):2631-2637. Chang YP.(2008)Prediabetes (IGT) is the optional time for intervention of diabetes and CVD.Diabetes Research and Clinical Practice,79,S6. Chen THH, Chiu YC, Luh DL, Yen MF, Wu HM,Chen LS, et al.(2004)Taiwan Community-based Integrated Screening Group.Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer.100(8):1734-1743. Chen HD,Shaw CK,Tseng WP,Chen HI.(1997)Prevalence of diabetes mellitus and impaired glucose tolerance in Aborigines and Chinese in eastern Taiwan, Diabetes Res.Clin.Pract.38 (3) ,199-205. Chen CC, Li TC, Chang PC,et al.(2008)Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metabolism.57(4):544-548. Cheng TO.(1995)Smoking in China.BMJ.310(6971):61. Chen CJ,Wang SL,Chiou JM,et al.(2007)Arsenic and diabetes and hypertension in human populations: a review.Toxicol Appl Pharmacol. 222(3):298-304. Cheng AY,Kong AP,Wong VW,et al.(2006)Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. Diabetologia.49(8):1777-1784. Chou P,Li CL,Wu GS,Tsai ST.(1998)Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen.Exploring the natural history of type 2 diabetes. Diabetes Care.21,1183-1187. Cho NH,Jang HC,Choi SH,et al.(2007)Abnormal liver function test predicts type 2 diabetes: a community-based prospective study. Diabetes Care. 30(10):2566-2568. Chiasson JL,Josse KG,Gomis R,Hanefeld M,Karasik A,Laakso M.(2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359,2072-2077. Chan WB, Tong PCY, Chow CC, et al.(2004) The associations of body mass index, C peptide and metabolic status in Chinese type 2 diabetic patients. Diabet Med.21(4):349-353. Daniel M,Rowley KG,McDermott R,O’Dea K.(2002)Diabetes and impaired glucose tolerance in Aboriginal Australians: prevalence and risk,Diabetes Res.Clin.Pract. 57 (1) 23-33. Deurenberg P,Deurenberg-Yap M,Guricci S.(2002)Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship. Obes Rev.3(3):141-146. Diabetes Prevention Program Research Group.(2002)Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346,393-403. Dowse G,Zimmet P,Finch C,Collins VS.(1991)Decline in incidence of epidemic glucose intolerance in Nauruans: implications for he ‘‘thrifty genotype’’,Am. J. Epidemiol.133,1093-1104. Executive summary of the third report of the National Cholesterol Education Program (NCEP)(2001) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).JAMA 285: 2486-2497. Fujiyoshi PT,Michalek JE,Matsumura F.(2006)Molecular epidemiologic evidence for diabetogenic effects of dioxin exposure in U.S.Air force veterans of the Vietnam war. Environ Health Perspect.114(11):1677-1683. Fukushima M,Usami M,Ikeda M,et al.,(2004) Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism.53(7): 831-835. Gao WG,Dong YH,Pang ZC, et al.,(2009)Epidemiology Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao,China.Diabetes Medicine,26,1220-1227. Genuth S,Albert KG,Bennett P,et al.(2003)Follow-up report on the diagnosis of diabetes mellitus.Diabetes Care,26:3160. Grandinetti A,Kaholokula JK,Crabbe KM,Kenui CK,Chen R,Chang HK, (2000)Relationship between depressive symptoms and diabetes among native Hawaiians, Psychoneuroendocrinology 25 (3) ,239-246. Gu D,Reynolds K,Duan X,et al.(2003)InterASIA Collaborative Group. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular.Disease in Asia (InterASIA). Diabetologia.46(9):1190-1198. Gu D,Reynolds K,Wu X,et al;InterASIA Collaborative Group.(2005)Prevalence of the metabolic syndrome and overweight among adults in China.Lancet. 365(9468):1398-1405. Henry RJ,et al.(2009)Trend Analysis of Diagnosed Diabetes Prevalence Among American Indian/Alaska Native Young Adults-United States, 1994-2007.Ethnicity of Diabetes,Volume 19,Summer. Huxley R,James WP,Barzi F,et al.(2008)Obesity in Asia Collaboration.Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension.Obes Rev.9(suppl 1):53-61. Hur NW,Kim HC,Nam CM,Jee SH,Lee HC,Suh I.(2007)Smoking cessation and risk of type 2 diabetes mellitus:Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil.14(2):244-249. Jan CF,Chen CJ,Chiu YH,Chen LS,Wu HM,Huang CC,Yen MF, Chen THH. (2006) A population-based study on the association between metabolic syndrome and hepatitis B/C virus infection (Keelung Community-based Integrated Screening Study No.10). International Journal of Obesity.1,1-6. Jiang R,Manson JE,Meigs JB,Ma J,Rifai N,Hu FB.(2004)Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 291(6):711-717. Juliana CN.Chan,Vasanti Malik,Weiping Jia,et al.(2009)Diabetes in Asia -epidemiology,Risk Factor, and Pathophysiology.JAMA,301(20), 2129-2140. K.G.M.M.Alberti.(2007)Screening and diagnosis of prediabetes:where are we headed?Diabetes,Obesity and Metabolism,9(Suppl.1),12-16. Kabir Z.,Clancy L,Connolly GN.(2007)Tobacco control efforts: where is India now? Lancet.370(9582):134. Kim SM,Lee JS,Lee J,et al.(2006)Prevalence of diabetes and impaired fasting glucose in Korea:Korean National Health and Nutrition Survey 2001.Diabetes Care.29(2):226-231. Kim HM,Park J,Kim HS,Kim DH,Park SH.(2006)Obesity and cardiovascular risk factors in Korean children and adolescents aged 10-18 years from the Korean National Health and Nutrition Examination Survey,1998 and 2001. Am J Epidemiol.164(8):787-793. Kim DM,Ahn CW,Nam SY.(2005)Prevalence of obesity in Korea. Obes Rev. 6(2):117-121. King H,Aubert RE,Herman WH.(1998) Global burden of diabetes,1995-2025. Diabetes Care 21,1414-1431. Ko GT,Chan JC,Tsang LW,Critchley JA,Cockram CS.(2001)Smoking and diabetes in Chinese men.Postgrad Med J.77(906):240-243. Lai H,Chiu YH,Lo MT,Wu CL,Chou KP,Jeng JH,Chen THH.(2008) Community-based randomized intervention trial for periodontal disease after 18-month follow-up [Keelung Community-based Integrated Screening (KCIS) No. 4] J Eval Clin Pract.14:507-12. Lao TT,Chan BC,Leung WC,Ho LF,Tse KY.(2007)Maternal hepatitis B infection and gestational diabetes mellitus.J Hepatol.47(1):46-50. Le DS,Kusama K,Yamamoto S.(2006)A community-based picture of type 2 diabetes mellitus in Vietnam.J Atheroscler Thromb.13(1):16-20. Lee ET,Howard BV,Savage PJ,Cowan LD, Fabsitz RR,Oopik AJ,et al.(1995) Diabetes and impaired glucose tolerance in three American Indian populations aged 45–74 years:the Strong Heart Study, Diabetes Care 18, 599-610. Lee DH,Steffes MW,Jacobs DR Jr.(2008)Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia.51(3):402-407. Leonard D,McDermott R,Odea K,Rowley KG,Pensio P,Sambo E,et al.(2002) Obesity, diabetes and associated cardiovascular risk factors among Torres Strait Islander people, Aust.N.Z.J.Public Health 26(2)144-149. Likitmasku S,Kiattisathavee P,Chaichanwatanakul K,Punnakanta L, Angsusingha K,Tuchinda C.(2003)Increasing prevalence of type 2 diabetes mellitus in Thai children and adolescents associated with increasing prevalence of obesity.J Pediatr Endocrinol Metab.16(1):71-77. Li CL,Tsai ST,Chou P.(2002)Comparison of metabolic risk profiles between subjects with fasting and 2-hour plasma glucose impairment:The Kinmen Study.J Clin Epidemiology 55,19-24. Lin JD,et al.(1993)Diabetes mellitus and hypertension based on the family history and 2-h postprandial blood sugar in the Ann-Lo district (Northern Taiwan).Diabetes Research and Clinical Practice, 20:75-85. Lindstrom J.et al.(2003) Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: Results from a randomized clinical trial. Journal of the American society of Nephrology, 14(7)(suppl 2):S108-S113. Little RA, Rubin DB.(2002)Statistical analysis with missing data (2nd Edition). Wiley. Little,RA & Rubin,DB. (1987)Statistical analysis with missing data. New York, Wiley. Lu FH,Yang YC,et al.(1998)A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med.Jul; 15(7):564-72. Maskarinec G, Grandinetti A, Matsuura G,et al.(2009)Diabetes prevalence and body mass index differ by ethnicity:the Multiethnic cohort.Ethnicity & Disease, Volume 19,49-55. Maureen I.Harris.Diabetes in America, 2nd Edition.NDIC. http://diabetes.niddk.nih.gov/dm/pubs/America/contents.htm Ma RCW,Ko GT,Chan JC.Health hazards of obesity-an overview.In:Williams G, Frubeck G,eds.Obesity:Science to Practice.Hoboken,NJ: John Wiley & Sons; 215-236. Mak KH,Ma S,Heng D,et al.(2007)Impact of sex, metabolic syndrome, and diabetes mellitus on cardiovascular events.Am J Cardiol.100(2):227-233. Mehta SH,Brancati F,Strathdee S,et al.(2003)Hepatitis C virus infection and incident type 2 diabetes.Hepatology.38(1):50-56. Misra A, Khurana L.(2008)Obesity and the metabolic syndrome in developing countries.J Clin Endocrinol Metab.93(11)(suppl 1):S9-S30. Miyake K,Horikawa Y,Hara K,et al.(2008)Association of TCF7L2 polymorphisms with susceptibility to type 2 diabetes in 4,087 Japanese subjects. J Hum Genet.53(2):174-180. Nakagami T,Qiao Q,Carstensen B,et al.(2003)The DECODE-DECODA Study Group.Age,body mass index and type 2 diabetes—associations modified by ethnicity.Diabetologia.46(8):1063-1070. Ng MC,Park KS,Oh B,et al.(2008)Implication of genetic variants near TCF7L2, SLC30A8,HHEX,CDKAL1,CDKN2A/B,IGF2BP2,and FTO in type 2 diabetes and obesity in 6,719 Asians.Diabetes.57(8):2226-2233. Ozaki R,Qiao Q,Wong GW,et al.(2007)Overweight, family history of diabetes and attending schools of lower academic grading are independent predictors for metabolic syndrome in Hong Kong Chinese adolescents. Arch Dis Child. 92(3):224-228. Perez-Bravo F,Carrasco E, Santos JL,Calvillan M,Larenas G,Albala C.(2001) Prevalence of type 2 diabetes and obesity in rural Mapuche population from Chile, Nutrition 17(3)236-238. Qiao Q et al.(2002)Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J.23(16):1267-75. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Diabetes Care.(1997)20(7):1183-97. Ramachandran Ambady,Snehalatha Chamukuttan.(2008)Early diagnosis and prevention of diabetes in developing countries. Rev Endocr Metab Disord,9, 193-201. Reaven GM(1999)Insulin resistance: a chicken that has come to roost.AnnNY Acad Sci. 892:45-57. Ren Q,Han XY,Wang F,et al.(2008)Exon sequencing and association analysis of polymorphisms in TCF7L2 with type 2 diabetes in a Chinese population. Diabetologia.51(7):1146-1152. Reynolds K,Gu D,Whelton PK,et al,(2007)InterASIA Collaborative Group. Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring)15(1):10-18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.(1997)Diabetes Care.20(7) :1183-97. Ruderman N,Chisholm D,Pi-Sunyer X,Schneider S.(1998)The metabolically obese, normal-weight individual revisited. Diabetes.47(5):699-713. Study Group on Diabetes Mellitus.(1985)WHO Technical Report Series 727, Geneva,9-12. Santos JL,Perez-Bravo F,Carrasco E,Calvillan M,Albala C.(2001)Low prevalence of type 2 diabetes despite a high average body mass index in the Aymara natives from Chile, Nutrition 17(4)305-309. Scragg R,Baker J,Metcalf P,Dryson E.(1991)Prevalence of diabetes mellitus and impaired glucose tolerance in a New Zealand multiracial workforce, N. Z. Med.J.104,395-397. Song KH,Nam-Goomg IS,Han SM,et al.(2007)Change in prevalence and 6-year incidence of diabetes and impaired fasting glucose in Korean subjects living in a rural area.Diabetes Res Clin Pract.78(3):378-384. Scharoun-Lee M,Kaufman JS,Popkin BM,Gordon-Larsen P.(2009)Obesity,race/ ethnicity and life course socioeconomic status across the transition from adolescence to adulthood. J Epidemiol Community Health.63(2):133-139. Stolk RP,Suriyawongpaisal P,Aekplakorn W,Woodward M,Neal B;InterASIA Collaborative Group.(2005)Fat distribution is strongly associated with plasma glucose levels and diabetes in Thai adults—the InterASIA study. Diabetologia.48(4):657-660. Sun L,Franco OH,Hu FB,et al.(2008)Ferritin concentrations, metabolic syndrome,and type 2 diabetes in middle-aged and elderly chinese. J Clin Endocrinol Metab.93(12):4690-4696. Sugarman JR, Gilbert TH,Weiss NS.(1992)Prevalence of diabetes and impaired glucose tolerance among Navajo Indians, Diabetes Care15,114-120. Shepard CW,Simard EP,Finelli L,Fiore AE,Bell BP.(2006)Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev.28:112-125. Shaw J.(2007) Diabetes,CVD and ethnicity; diverse patterns across the Western Pacific Region. Diabetes Research and Clinical Practice,79,S6-S7. Taylor R,Bennett P,Uili R,Joffres M,Germain R,Levy,S.et al.(1985)Diabetes in Wallis Polynesians: a comparison of residents of Wallis Island and first generation migrants to Noumea,New Caledonia, Diabetes Res. Clin.Pract.1 (3)169-178. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.(2003)Diabetes Care 26 (Suppl 1):S5-S20. Tsai ST,et al.(2000)Community-based epidemiological study of glucose tolerance in Kin-Chen Kinmen :support for a new intermediate classification . Journal of Clinical Epidemiology 53,505-510. Tseng CH,Chong CK,et al.(2000)The incidence of type 2 diabetes mellitus in Taiwan. Diabetes Research and Clinical Practice 50 Suppl.2,S61-S64. Tuomilehto J,Lindstrom J,Eriksson JG,Valle TT,et al.(2001)Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.N Engl J Med; 344,1343-1350. Tung TH,Chiu YH,Wu HM,Boucher BJ,Chen THH.(2004)A population-based study of the association between areca-nut chewing and type 2 diabetes mellitus in men (KCIS No. 2) Diabetologia.47:1776-81. Thomas GN,Schooling CM,McGhee SM,et al.(2007)Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. Metabolic syndrome in- creases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clin Endocrinol (Oxf ).66(5):666-671. WHO/IDF Concultation.(2006)Definition and Diagnosis of Diabetes Mellitus and intermediate Hyperglycemia:Report of a WHO/IDF Consultation. Geneva:World Health Organization /International Diabetes Federation. World Health Organization,Definition,Diagnosis and Classification of Diabete Mellitus and its Complications,Report of a WHO Consultation.Part 1. Diagnosis and Classification of Diabetes Mellitus,Geneva,Department of Noncommunicable Disease Surveillance. World Health Organization.(1985)WHO Expert Committee on Diabetes Mellitus. Second report,Technical Report Series 646.Geneva:World Health Organization. Wang Y,Mi J,Shan XY,Wang QJ,Ge KY.(2007)Is China facing an obesity epidemic and the consequences?The trends in obesity and chronic disease in China. Int J Obes (Lond)31(1):177-188. Wang C,Hou X,Bao Y,et al.(2008)The metabolic syndrome increased risk of cardiovascular events in Chinese-a community based study [published on- line ahead of print November 27, 2008]. Int J Cardiol.doi:10.1016/ j.ijcard. 10.012. Willi C,Bodenmann P,Ghali WA,Faris PD,Cornuz J.(2007)Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 298(22):2654-2664. Wild S, Roglic G, Green A,et al.(2004)Global Prevalence of Diabetes.Estimates of the year 2000 and projections for 2030. Diabetes Care,27,1047-1053. Whincup PH,Kaye SJ,Owen CG,et al.(2008)Birth weight and risk of type 2 diabetes:a systematic review.JAMA.300(24):2886-2897. Wu Y,Li H,Loos RJ,et al.(2008)Common variants in CDKAL1,CDKN2A/B, IGF2BP2,SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.Diabetes. 57(10) :2834-2842. Yu CH,Zinman B.(2007)Type 2 diabetes and impaired glucose tolerance in aboriginal populations: a global perspective. Diabetes Research and Clinical Practice.78,378-384. Yoon KH,Lee JH,Kim JW,et al.(2006)Epidemic obesity and type 2 diabetes in Asia. Lancet.368(9548):1681-1688. Zhou H,Yamauchi T,Natsuhara K,et al.(2006)Overweight in urban schoolchildren assessed by body mass index and body fat mass in Dalian, China. J Physiol Anthropol.25(1):41-48. Zhang X ,Shu XO,Yang G,et al.(2007)Abdominal adiposity and mortality in Chinese women. Arch Intern Med.167(9):886-892. 行政院衛生署(2010).97年度衛生統計動向-死因統計.2010年4 月取自 http://www.doh.gov.tw/CHT2006/DM/DM2_2.aspx?now_fod_list_no=10987&class_no=440&level_no=2. 行政院衛生署(2000).糖尿病共同照護工作指引手冊。 陳建仁等,台灣地區高血糖、高血脂、高血壓盛行率調查。(2002), http://www.bhp.doh.gov.tw/health91/study-2.htm 郭育倫等(2008)100健康亮紅燈•126糖尿病上身-多元衛教介入對糖尿病前期者之成效探討。實證護理, Vol.4 No.4, 297-306. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48347 | - |
dc.description.abstract | 背景 國內外有關糖尿病前期進展到糖尿病的相關研究中,多為單次或二次的橫斷式調查資料,且大多為盛行率調查報告,關於發生率報告很少,且缺乏長期時間觀察結果及以社區群體為基礎的實證研究。此外,由血糖正常期進展至糖尿病盛行率資料較常見,由糖尿病前期進展至糖尿病等研究則相當少見。
研究目的 本論文擬以基隆市社區闔家歡篩檢為基礎,探討基隆市糖尿病及糖尿病前期盛行率、發生率及相關危險因子。 材料與方法 本論文的研究族群來自於參與基隆市社區闔家歡篩檢的民眾,該篩檢計畫為一整合性篩檢服務計畫,主要針對設籍基隆市年滿20歲以上的民眾提供包括癌症及慢性病篩檢,並利用結構式問卷收集生活習慣及個人病史等資料。自2000年至2009年間,共259,875人次參加社區闔家歡健康篩檢,排除未抽血者、未滿20歲及非設籍者,共有247,649人次參加篩檢,扣除重複參加次數,篩檢世代共107,501人,其中男性占39.7%,女性占60.3%,涵蓋率約37.1%。 在篩檢服務計畫中,除了利用空腹血漿血糖及個人病史確認第二型糖尿病之外,於2002~2005年針對空腹血糖介於110~125 mg/dL及2006年後100~125 mg/dL的族群轉診進行口服葡萄糖耐量試驗,並確定是糖尿病或「葡萄糖耐受性異常」(Impaired glucose tolerance ,IGT)。 不同性別、年齡別之下葡萄糖耐受性異常及糖尿病盛行率及發生率,並利用2000年世界標準人口進行年齡標準化計算。以羅吉斯迴歸模式分析糖尿病盛行的危險因子,並以卜瓦松迴歸模式分析糖尿病發生率的危險因子。此外,亦利用比例危險迴歸模式分析正常、葡萄糖耐受性異常及糖尿病的危險因子。由於口服葡萄糖耐量試驗轉介率僅約50%,因此本論文分別以Missing complete at random (MCAR)及Missing at random (MAR)的原則插補未轉介個案的疾病狀態。 結果 本計畫共計107,501人參與闔家歡篩檢計畫,取其第一次參加篩檢資料為本研究盛行率計算的分析世代,其中約52%的個案(55,983人)曾經接受重覆篩檢,為本研究發生率計算的分析世代。結果發現在2005年之前高血糖個案需轉介口服葡萄糖耐量試驗者約為4%,因2002年才開始進行轉介,轉介率40.2%,2006年之後的高血糖需轉介個案約佔12%,轉介率54.0%,平均轉介率約為50%。高血糖轉介完成的個案中,在2005年之前約有29%被確認為糖尿病、34%為葡萄糖耐受性異常,在2006年之後則分別為18%及34%。 本篩檢世代計有9,288位糖尿病盛行個案,盛行率約8.6%,男性盛行率10.1%,高於女性之7.7%,盛行率在男性及女性均隨著年齡增加而增加。經轉介OGTT 2小時血糖介於140~199 mg/dL間,診斷為IGT有567人,盛行率約0.53%,男性約0.63%,女性約0.46%。糖尿病年齡標準化盛行率於男性為7.70%,女性為6.53%,整體為6.95%;IGT年齡標準化盛行率為0.51%,女性為0.40%,整體為0.44%。以MCAR調整後,年齡標準化後的糖尿病盛行率為7.6%,男性為8.4%,女性為7.2%,IGT推估盛行率為1.3%,男性為1.4%,女性為1.2%;若以MAR調整,年齡標準化後的糖尿病盛行率為7.6%,男性為8.4%,女性為7.2%,IGT推估盛行率為1.3%,男性為1.5%,女性為1.2%。 影響糖尿病盛行率之相關因子,包括年齡(OR=1.048, 95%CI: 1.046-1.05)、男性(OR=1.06, 95%CI: 1.01-1.11)、肥胖(OR=1.20, 95%CI:1.14-1.28)、高血壓(OR=1.70, 95%CI:1.61-1.79)、嚼檳榔(OR=1.16, 95%CI:1.02-1.32)、腹部肥胖(OR=1.81, 95%CI:1.71-1.92)、高膽固醇(OR=0.79, 95%CI:0.73-0.87)、高三酸甘油酯(OR=2.40, 95%CI: 2.28-2.52)及C型肝炎(OR=1.16, 95%CI:1.04-1.30)等因子,在互相調整後仍與糖尿病有顯著相關,但除高膽固醇與糖尿病在多變量分析中呈現負相關外,其餘因子皆與糖尿病呈正相關。以比例危險迴歸分析影響糖尿病盛行率之相關因子,其結果與羅吉斯迴歸分析結果差異不大。 發生率方面,基隆市20歲以上民眾糖尿病發生率約為1.58%,其中男性發生率2.01%高於女性1.37%,男性糖尿病標準化發生率為1.295%,女性糖尿病標準化發生率為0.983%,整體而言,基隆市社區糖尿病標準化發生率為1.087%,不論何種年齡層男性糖尿病發生率皆高於女性。進一步分析篩檢世代追蹤年間各組糖尿病發生率,由正常血糖值進展至IGT發生率約0.83%,男性0.97%高於女性0.76%;由正常血糖值進展至糖尿病發生率約1.33%,男性1.72%高於女性1.14%;以上發生率均隨年齡增加而增加。由IGT進展至糖尿病發生率約17.46%,男性17.00%略低於女性17.78%,值得注意的是IGT返回正常血糖值發生率高達35.28%。 影響糖尿病發生率之相關因子,包括年齡(RR=1.035, 95%CI: 1.032-1.038)、肥胖(RR=1.57, 95%CI: 1.45-1.71)、高血壓(RR=1.46, 95%CI: 1.36-1.57)、吸菸(RR=1.16, 95%CI: 1.06-1.28)、嚼檳榔(RR=1.31, 95%CI:1.07-1.60)、腹部肥胖(1.75, 95%CI: 1.61-1.91)、高膽固醇(RR=1.28, 95%CI: 1.11-1.48)、高三酸甘油酯(RR=1.80, 95%CI: 1.67-1.93)、C型肝炎(RR=1.27, 95%CI: 1.08-1.49)等因子,在相互調整後皆為糖尿病危險因子。 結論 本研究為全世界少數以族群為主的大規模糖尿病流行病學世代追蹤研究,所提供社區糖尿病及糖尿病前期之盛行及發生訊息,相當重要且可貴,藉由本研究的重要發現,能進一步幫助臨床及公共衛生決策者,在制訂糖尿病防治策略時,有此實證資料以為參考之依據。 | zh_TW |
dc.description.abstract | Background: Type 2 diabetes and its associated complications are major contributions to deaths in developed countries. It also causes serious medical burden in society. Therefore, the understanding of the epidemiological profile of type 2 diabetes plays important role in medical source allocation and planning. There is lacking long-term longitudinal and community-based study in the literatures. The aim of the current study was to investigate the prevalence, incidence, and risk factors for type 2 diabetes based on Keelung Community-based Integrated Screening (KCIS).
Materials and Methods: The study population was from the attendee of KCIS, which targeted at residents in Keelung and aged 20 years or above with screening for three chronic diseases and five cancers. In addition to biochemical examination, information of life style, personal history, and family history were collected with a structured questionnaire. A total of 259,875 visits were made by 107,501 subjects between 2000 and 2009 (Male 39.7%, Female: 60.3%), covering 37.1% population aged 20 years and above in Keelung. In the KCIS program, type 2 diabetes was ascertained with fasting glucose >=126 mg/dl or self-report. In addition, for those with elevated fasting glucose but not reached the level of type 2 diabetes (110-125 mg/dl before 2005 and 100-125 mg/dl after 2006) were referred for OGTT (Oral Glucose Tolerance test) to identify cases of IGT (Impaired glucose tolerance) or type 2 diabetes. This thesis reports the age- and gender-specific prevalence and incidence of IGT and type 2 diabetes. Age-standardized figures were calculated in the light of 2000 World standard population. Logistic regression models and Poisson regression model were used to identify risk factors for the prevalence and the incidence of type 2 diabetes, respectively. Proportional odds models were used to identify risk factors for IGT and type 2 diabetes treating as different disease status simultaneously. Missing complete at random and missing at random were applied to implement the missing values of disease status for those refusing OGTT referral. Results: Among the 107,501 subjects in the KCIS program, 52% received more than one screening. The were 4% needed to refer for OGTT before 2005, and 12% after 2006. The referral rates were 40.2% before 2005 and 54.0% after 2006. The proportions of IGT and type 2 diabetes among those referred were 34% and 29% before 2005 and 34% and 18% after 2006. In Keelung, the crude prevalence of type 2 diabetes was 8.6% (male: 10.1%, female 7.7%), increasing with advancing age. The age-standardized figure was 6.95% (7.7% for male and 6.53 for female). For IGT, the age-standardized figure was 0.51% (male 0.51%, female 0.40%). With adjustment in the light of MCAR method, the age standardized prevalence was 7.6% for type 2 diabetes, and 1.3% for IGT. The figures were similar with adjustment in the light of MAR method. Significant risk factors affecting prevalence of type 2 diabetes included age (OR=1.048, 95%CI: 1.046-1.05), male(OR=1.06, 95%CI: 1.01-1.11), elevated BMI(OR=1.20, 95%CI:1.14-1.28), hypertension(OR=1.70, 95%CI:1.61-1.79), betel quid chewing (OR=1.16, 95%CI:1.02-1.32), central obesity (OR=1.81, 95%CI:1.71-1.92), elevated cholesterol (OR=0.79, 95%CI:0.73-0.87), elevated triglyceride(OR=2.40, 95%CI: 2.28-2.52), and anti-HCV(OR=1.16, 95%CI:1.04-1.30) in the multivariate logistic regression model. The proportional odds model found similar risk factors for IGT and type 2 diabetes. The crude incidence for type 2 diabetes was 1.58% (male: 2.01%, female: 1.37%). The standardized incidence for type 2 diabetes was 1.087% (male 1.295%, female: 0.983). The transition rate was 0.83% from normal to IGT, 1.33% from normal to type 2 diabetes, 17.46% from IGT to type 2 diabetes, but as high as up to 35% for regression from IGT to normal. Factors affecting the incidence of type 2 diabetes include age(RR=1.035, 95%CI: 1.032-1.038), elevated BMI (RR=1.57, 95%CI: 1.45-1.71), hypertension (RR=1.46, 95%CI: 1.36-1.57), smoking (RR=1.16, 95%CI: 1.06-1.28), betel quid chewing (RR=1.31, 95%CI:1.07-1.60), central obesity (1.75, 95%CI: 1.61-1.91), elevated cholesterol (RR=1.28, 95%CI: 1.11-1.48), elevated triglyceride (RR=1.80, 95%CI: 1.67-1.93), anti HCV (RR=1.27, 95%CI: 1.08-1.49) in the multivariable Poisson regression model. Conclusion: This study is one of the few studies investigating the epidemiological profile for incidence and prevalence of type 2 diabetes with longitudinal and community-based study. The results of study are anticipated to aid public health decision-makers. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T06:53:24Z (GMT). No. of bitstreams: 1 ntu-100-P96842005-1.pdf: 711040 bytes, checksum: 9d90a5db88f9e12f78a2feabd7c4ad79 (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | 口試委員會審定書 i
致謝 ii 中文摘要 iii Abstract vi 第一章 前言 1 1.1 研究背景 1 1.2 研究動機與目的 1 第二章 文獻回顧 3 2.1糖尿病與糖尿病前期 3 2.2 糖尿病流行病學現況 4 2.2.1 地區及種族間差異 4 2.2.2 亞洲地區 5 2.2.3 台灣地區糖尿病主要流行病學調查 6 2.3 糖尿病前期及主要流行病學現況 8 2.4 糖尿病相關危險因子 10 2.5 糖尿病診斷標準 13 第三章 材料與方法 20 3.1目標族群(Target population) 20 3.2 硏究族群(Study population) 20 3.3 資料收集:利用基隆市社區闔家歡健康篩檢(Keelung Community-based Integrated Screening ,KCIS)平台 21 3.4 口服葡萄糖耐量試驗(Oral Glucose Tolerance test, OGTT) 23 3.5 糖尿病及糖尿病前期之操作型定義 23 3.6問卷內容及資料結構 24 3.7 統計分析方法 25 第四章 結果 31 4.1 研究對象基本資料描述 31 4.2 OGTT轉介結果及發現 32 4.3 基隆市社區糖尿病盛行情形 33 4.4 基隆市社區糖尿病盛行相關危險因子 35 4.5基隆市社區糖尿病發生情形 38 4.6基隆市社區糖尿病發生相關危險因子 39 第五章 討論 41 參考文獻 66 | |
dc.language.iso | zh-TW | |
dc.title | 社區第二型糖尿病流行病學初探~以社區長期追蹤世代分析 | zh_TW |
dc.title | Epidemiology of Type 2 Diabetes with Community-based Longitudinal Cohort | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 戴政,張淑惠,黃崑明 | |
dc.subject.keyword | 糖尿病,口服葡萄糖耐性試驗,葡萄糖耐受不良,空腹血糖異常,糖尿病前期,盛行率,發生率,危險因子, | zh_TW |
dc.subject.keyword | Diabetes Mellitus,Oral Glucose Tolerance test,Community-based,Impaired glucose tolerance,Impaired Fasting Glucose,pre-diabetes,prevalence,incidence,risk factor., | en |
dc.relation.page | 78 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2011-02-12 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 694.38 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。